Lourens J. D. Zaneveld

Lourens J. D. Zaneveld's AcademicInfluence.com Rankings

Biology

#13539

World Rank

#17090

Historical Rank

biology Degrees

Download Badge

Biology

Lourens J. D. Zaneveld's Degrees

PhD Biomedical Sciences University of California, San Diego
Masters Biomedical Sciences University of California, San Diego
Bachelors Biomedical Sciences University of California, San Diego

Why Is Lourens J. D. Zaneveld Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lourens J. D. Zaneveld's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics. (1984) (1679)
Chemistry and pharmacology of the citrus bioflavonoid hesperidin (2001) (716)
The hypoosmotic swelling test: an update. (1992) (199)
Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins. (1975) (194)
Inhibition of fertilization in vivo by pancreatic and seminal plasma trypsin inhibitors. (1971) (147)
A simple, clinical assay to evaluate the acrosin activity of human spermatozoa. (1989) (147)
Correlation between human sperm swelling in hypoosmotic medium (hypoosmotic swelling test) and in vitro fertilization. (1986) (141)
Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM). (2001) (110)
Papillomavirus Microbicidal Activities of High-Molecular-Weight Cellulose Sulfate, Dextran Sulfate, and Polystyrene Sulfonate (2001) (108)
Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent. (2002) (103)
Development and Characterization of Bioadhesive Vaginal Films of Sodium Polystyrene Sulfonate (PSS), a Novel Contraceptive Antimicrobial Agent (2005) (101)
Candidate Topical Microbicides Bind Herpes Simplex Virus Glycoprotein B and Prevent Viral Entry and Cell-to-Cell Spread (2004) (100)
Ethanol-induced male infertility: impairment of spermatozoa. (1983) (99)
Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. (2000) (92)
Relationship of a trypsin-like enzyme in rabbit spermatozoa to capacitation. (1969) (92)
In vitjro spermicidal activity of gossypol. (1980) (88)
Acrosomal Proteinase and Proteinase Inhibitor of Human Spermatozoa (1972) (83)
Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging. (1998) (83)
Effect of abstinence on sperm acrosin, hypoosmotic swelling, and other semen variables. (1992) (72)
Assemblies for In Vitro Measurement of Bioadhesive Strength and Retention Characteristics in Simulated Vaginal Environment (2002) (71)
Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges. (2003) (70)
Evidence for a role of cyclooxygenase (prostaglandin synthetase) and prostaglandins in the sperm acrosome reaction and fertilization. (1987) (69)
Properties of a proteolytic enzyme from rabbit sperm acrosomes. (1972) (69)
Mandelic Acid Condensation Polymer: Novel Candidate Microbicide for Prevention of Human Immunodeficiency Virus and Herpes Simplex Virus Entry (2002) (67)
Purification of a proteolytic enzyme from rabbit acrosomes. (1972) (67)
Mammalian Sperm Acrosomal Enzymes and the Acrosome Reaction (1991) (67)
Human sperm selection by glass wool filtration and two-layer, discontinuous Percoll gradient centrifugation. (1989) (64)
A sperm enzyme that disperses the corona radiata and its inhibition by decapacitation factor. (1970) (62)
Properties of acrosomal hyaluronidase from bull spermatozoa. Evidence for its similarity to testicular hyaluronidase. (1973) (62)
Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status. (1998) (61)
Two Novel Vaginal Microbicides (Polystyrene Sulfonate and Cellulose Sulfate) Inhibit Gardnerella vaginalis and Anaerobes Commonly Associated with Bacterial Vaginosis (2002) (61)
Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel. (1999) (59)
Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases. (2000) (58)
Laser-Induced Thermal Damage of Skin (1977) (58)
A proteinase and proteinase inhibitor of mammalian sperm acrosomes. (1973) (57)
Comparison of glycerol and a zwitter ion buffer system as cryoprotective media for human spermatozoa. Effect on motility, penetration of zona-free hamster oocytes, and acrosin/proacrosin. (1984) (56)
Compendium of Pharmaceutical Excipients for Vaginal Formulations (2001) (56)
Mammalian sperm acrosomal neuraminidases. (1970) (55)
A high molecular weight antifertility factor from human seminal plasma. (1979) (53)
Ethanol-induced male reproductive tract pathology as a function of ethanol dose and duration of exposure. (1983) (51)
Biochemistry of mammalian reproduction (1982) (51)
Efficacy and Safety of a New Vaginal Contraceptive Antimicrobial Formulation Containing High Molecular Weight Poly(Sodium 4-Styrenesulfonate)1 (2002) (50)
Acrosomeless Sperm. A Cause of Primary Male Infertility (2009) (48)
Biochemical Changes in the Zona Pellucida of Rabbit Ova Induced by Fertilization and Sperm Enzymes (1971) (47)
Hormonal imbalance and alterations in testicular morphology induced by chronic ingestion of ethanol. (1980) (47)
Male reproductive tract sensitivity to ethanol: A critical overview (1983) (46)
Inhibition of human sperm capacitation by a high-molecular-weight factor from human seminal plasma. (1982) (44)
Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product. (2006) (41)
A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. (2006) (41)
Acrosomal enzymes of human spermatozoa before and after in vitro capacitation. (1983) (40)
Trypsin Inhibitors and Fertilization (1971) (40)
Alterations of male reproduction induced by chronic ingestion of ethanol: development of an animal model. (1978) (40)
Radiographic study of fluid transport in the rabbit vas deferens during sexual rest and after sexual activity. (1980) (39)
Development pharmaceutics of microbicide formulations. Part I: preformulation considerations and challenges. (2003) (39)
Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis. (2002) (39)
Gossypol inhibition of acrosin and proacrosin, and oocyte penetration by human spermatozoa. (1983) (39)
Acrosin, proacrosin, and acrosin inhibitor of guinea pig spermatozoa capacitated and acrosome-reacted in vitro. (1981) (38)
Diffusable proteins of the mucosa of the human cervix, uterus, and fallopian tubes: distribution and variations during the menstrual cycle. (1985) (38)
Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product. (2004) (38)
Treatment of human spermatozoa with an egg yolk medium can enhance the outcome of in vitro fertilization. (1989) (37)
Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS. (1998) (36)
Proacrosin activation and acrosin release during the guinea pig acrosome reaction (1990) (36)
Motility and Enzyme Activity of Human Spermatozoa Stored for 24 Hours at +5° C and −196° C * (1980) (35)
Relationship between semen characteristics and fertility in electroejaculated mice. (1983) (35)
Inhibition of in-vitro fertilization of mouse gametes by proteinase inhibitors. (1982) (34)
Acrosin of mouse spermatozoa. (1979) (33)
Purification and partial chemical characterization of a glycoprotein with antifertility activity from human seminal plasma. (1987) (33)
Tetratological evaluation of mouse fetuses after paternal alcohol ingestion. (1981) (32)
Detergent treatment of human and rabbit spermatozoa: ultrastructural changes and release of midpiece enzymes. (1974) (32)
Inhibition by Seminal Plasma of Acrosomal Enzymes in Intact Sperm (1970) (31)
Delayed pubertal development of the male reproductive tract associated with chronic ethanol ingestion. (1987) (31)
Association of the in-vitro fertilizing capacity of human spermatozoa with sperm morphology as assessed by three classification systems. (1986) (31)
Inhibition of fertilization in the hamster by sodium aurothiomalate, a hyaluronidase inhibitor. (1980) (30)
Inhibition of human sperm penetration into zona-free hamster oocytes by proteinase inhibitors. (1985) (30)
Enzymic determination of fructose in seminal plasma by initial rate analysis. (1979) (30)
An acrosin-acrosin inhibitor complex in ejaculated boar sperm. (1971) (30)
Inhibition of mouse sperm capacitation by ethanol. (1982) (30)
Purification of plasminogen activators from human seminal plasma. (1978) (29)
Biochemical and structural evidence for ethanol-induced impairment of testicular development: apparent lack of Leydig cell involvement. (1989) (29)
Scanning electron microscopy of mammalian spermatozoa. (1971) (29)
Effect of Glycerol and Cryopreservation on Oocyte Penetration by Human Spermatozoa * (2009) (29)
Biological activity assessment of a novel contraceptive antimicrobial agent. (2005) (28)
Structural aspects of human cervical mucus. (1975) (28)
SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell‐mediated HIV transmission (2007) (28)
[Prevention of sexually transmitted diseases in women: association with socioeconomic and demographic variables]. (2001) (28)
Effects of various conditions of semen storage on the acrosin system of human spermatozoa. (1981) (28)
Effect of egg yolk medium on the acrosome reaction of human spermatozoa. (1990) (27)
Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products. (2003) (27)
Induction of the human sperm acrosome reaction by human oocytes. (1988) (26)
Modern Assessment of Semen for Diagnostic Purposes (1988) (26)
Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. (2003) (26)
[Human acrosin: kinetics of the inhibition by inhibitors from human sera]. (1972) (26)
Controversies in the development and validation of new sperm assays. (1993) (25)
Distribution of spermatozoa in the rabbit vas deferens. (1979) (25)
Inhibition of human sperm acrosin by synthetic agents. (1976) (25)
Nonbeneficial effects of glycerol on the oocyte penetrating capacity of cryopreserved and incubated human spermatozoa. (1985) (24)
Properties of a highly purified antifertility factor from human seminal plasma. (1982) (24)
Vaginal contraceptive activity of aryl 4-guanidinobenzoates (acrosin inhibitors) in rabbits. (1985) (24)
Women's preferences for vaginal antimicrobial contraceptives. I. Methodology. (1998) (24)
Demonstration of a functional blood-testis barrier to acetaldehyde. Evidence for lack of acetaldehyde effect on ethanol-induced depression of testosterone in vivo. (1985) (24)
A new technique to measure the liquefaction rate of human semen: the bag method. (1980) (24)
Vaginal spermicidal activity of gossypol in the Macaca arctoides. (1982) (22)
Scanning electron microscopy of the human, guinea-pig and rhesus monkey seminal coagulum. (1974) (21)
Relationship of human sperm acrosin and proacrosin to semen parameters. II. Correlations. (1987) (21)
Release of Acrosin and Acrosin Inhibitor from Human Spermatozoa**Supported by National Institutes of Health Grant HD09868 and World Health Organization Grant M8/181/4/B-124.††Presented at the Meeting of the Federation of American Societies for Experimental Biology, 1977, Chicago, Ill. (1978) (21)
Components of human split ejaculates. II. Enzymes and proteinase inhibitors. (1976) (21)
Contraception by Ushercell (cellulose sulfate) in formulation: duration of effect and dose effectiveness. (2004) (21)
Contribution of prostatic fluid components to the ejaculate. (1981) (20)
Development of a reversible vas deferens occlusive device. I. Anatomical size of the human and dog vas deferens. (1974) (20)
Acrosin inhibitors as vaginal contraceptives in the primate and their acute toxicity. (1979) (20)
Hemorrhage induced by intrauterine devices: control by local proteinase inhibition. (1977) (20)
Vaginal contraceptive activity of hyaluronidase and cyclooxygenase (prostaglandin synthetase) inhibitors in the rabbit. (1985) (19)
Synthesis and inhibition of human acrosin and trypsin and acute toxicity of aryl 4-guanidinobenzoates. (1986) (19)
Human sperm acrosomal proteinase: antibody inhibition and immunologic dissimilarity to human pancreatic trypsin. (1973) (18)
Semen Quality and In‐vitro Fertilization (1989) (18)
Proteinase Inhibitors in Human Cervical Mucus and Their in vitro Interactions with Human Acrosin (1974) (18)
Characterization and inhibitor sensitivity of human sperm phospholipase A2: Evidence against pivotal involvement of phospholipase A2 in the acrosome reaction (1990) (17)
Primate model for the evaluation of vaginal contraceptives. (1977) (17)
Development of a reversible vas deferens occlusive device. 3. Morphology of the human and dog vas deferens: a study with the scanning electron microscope. (1974) (17)
Postcoital, Vaginal, spermicidal potency of formulations: the Macaca arctoides (stumptailed macaque) as animal model. (1981) (17)
Development of a potentially reversible vas deferens occlusion device and evaluation in primates. (1988) (17)
Effect of serum proteinase inhibitors on the fertilizing capacity of rabbit spermatozoa. (1976) (17)
First pregnancies and livebirths from transfer of sodium alginate encapsulated embryos in a rodent model. (1993) (16)
Quality assurance for sperm concentration using latex beads. (1993) (16)
Release, extraction, and stability of hyaluronidase associated with human spermatozoa. Comparisons with the rabbit. (1985) (16)
Effects of peritoneal fluids from patients with endometriosis on capacitated spermatozoa. (1993) (16)
Effect of aryl 4-guanidinobenzoates on the acrosin activity of human spermatozoa. (1987) (15)
PARTIAL REVERSAL OF ETHANOL OF ETHANOL-INDUCED MALE REPRODUCTIVE PATHOLOGY FOLLOWING ABSTINENCE (1985) (15)
Proteinase Inhibitors and Proteinases of Human Semen (1974) (15)
Scanning Electron Microscopy of Cervical Mucus Crystallization (1975) (15)
The human uterotubal junction: a scanning electron microscope study during different phases of the menstrual cycle. (1976) (15)
Inhibition of human acrosin by fructose and other monosaccharides. (1980) (14)
Synthesis of diastereomeric ketoconazole analogs (1990) (14)
Development of reversible vas deferens occlusive device: V. Flexible prosthetic devices. (1975) (14)
Human sperm hypoosmotic swelling test. (1986) (14)
A new vaginal antimicrobial contraceptive formulation: phase I clinical pilot studies. (2000) (14)
Characterization of cysteamine as a potential contraceptive anti-HIV agent. (1998) (14)
Hypo-osmotic swelling test: analysis of prevasectomy ejaculates. (1990) (13)
The effect of ketoconazole on fertility of male rats. (1990) (13)
Lack of tubal occlusion by intrauterine quinacrine and tetracycline in the primate. (1984) (13)
Gossypol: pharmacology and current status as a male contraceptive (1985) (13)
Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices. (1981) (13)
Orally administered ketoconazole rapidly appears in seminal plasma and suppresses sperm motility (1985) (13)
Effect of heterologous seminal plasma on the fertilizing capacity of human spermatozoa as assessed by the zona-free hamster egg test. (1983) (12)
Polyamine inhibition of the conversion of human proacrosin to acrosin. (1979) (12)
Antifertility activity of systemically administered proteinase (acrosin) inhibitors. (1982) (12)
Osmo-sensitivity of the human sperm acrosome reaction. (1993) (11)
Chronic ethanol ingestion during puberty alters the transient increase in testicular 5 alpha-reductase in the Swiss-Webster mouse. (1989) (11)
Release of acrosin inhibitor from human spermatozoa. (1978) (11)
Development of reversible vas deferens occlusive device: IV. Rigid prosthetic devices. (1975) (11)
Contractions of the rabbit vas deferens following sexual activity: a mechanism for proximal transport of spermatozoa. (1980) (11)
SAMMA induces premature human acrosomal loss by Ca2+ signaling dysregulation. (2006) (11)
Long-term evaluation of the effect of catheter materials on urethral tissue in dogs. (1982) (10)
Effect of the intrauterine contraceptive device on protein components of human uterine fluid. (1993) (10)
Development and evaluation of an inhibitor-releasing matrix for intrauterine devices. (1982) (9)
Partial reversal of ethanol-induced male reproductive pathology following abstinence. (1985) (9)
Evidence for multiple catalytic sites of human acrosin from kinetic evaluation of fructose-induced acrosin inhibition. (1985) (9)
Comparison of the spermicidal activity and acute toxicity of nonoxynol-9 and agent 741 [alkylphenoxy polyethoxy ethanol(10)]. (1986) (9)
Scanning electron microscopy of mammalian gametes (2004) (8)
Womens preferences for vaginal antimicrobial contraceptives III (1998) (8)
Scanning electron microscopy of human female reproductive tract and amniotic fluid cells. (1977) (8)
An improved assay technique for the proteolytic activity of individual human spermatozoa. (1978) (8)
Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents. (2001) (8)
The role of acrosin in sperm penetration through human cervical mucus. (1979) (8)
Nonhormonal mediation of male reproductive tract damage: data from contraceptive drug research. (1989) (8)
Immunological and biochemical studies on fractionated bull spermatozoa. (1974) (7)
Efficacy, safety, and reversibility of a bisdiamine male-directed oral contraceptive in gray wolves (Canis lupus) (1996) (7)
Ethanol-induced delayed male puberty in mice is not due to impaired Leydig cell function. (1989) (7)
Testosterone production by the prepubertal mouse testis is not depressed by ethanol. (1989) (7)
Survey of vaginal formulations available on the Indian market: physicochemical characterization of selected products (2002) (7)
Transcervical tubal occlusion with a steerable hysteroscope: implantation of devices into extirpated human uteri. (1977) (7)
Development of a reversible vas deferens occlusive device. VI. Long-term evaluation of flexible prosthetic devices. (1979) (6)
Human spermatozoa do not undergo the acrosome reaction during storage in the cervix. (1991) (6)
Inhibition of human acrosin by monosaccharides and related compounds: structure-activity relationships. (1981) (6)
Evaluation of the in vivo efficacy of a new vaginal contraceptive agent in stumptailed macaques. (1984) (6)
Cervical mucus penetration test for in vitro assay of vaginal contraceptive agents. (1981) (6)
The effect of temperature on sperm motility and viability. (1981) (6)
The Acrosomal Enzymes of Mammalian Spermatozoa (1975) (5)
Development of the polyurethane sponge as a delivery system for aryl 4-guanidinobenzoates. (1988) (5)
Treatment of cervical mucus with lectins: effect on sperm migration. (1985) (5)
Functional Biochemistry of cervical mucus. (1979) (5)
Effect of sodium alginate encapsulation on the development of preimplantation mouse embryos (1987) (5)
Comparative vaginal spermicidal studies in the stumptailed macaque with alkyloxynol-741, nonoxynol-9 and chlorhexidine. (1990) (4)
Development of a polymeric releasing device for 2'-carbomethoxyphenyl 4-guanidinobenzoate (a proteinase inhibitor): release rate, in vitro antifibrinolytic activity and in utero contraceptive effect. (1988) (4)
Sperm enzyme inhibitors for vaginal and other contraception. (1982) (4)
Glass wool-filtered spermatozoa and their oocyte penetrating capacity (1989) (4)
Motility and enzyme activity of human spermatozoa stored for 24 hours at +5 degrees C and -196 degrees C. (1980) (4)
Rabbit gametes: scanning electron microscopy at early stages of fertilization. (1971) (4)
Biochemistry of mammalian reproduction. I. Gametes and genital tract fluids. II. Reproductive endocrinology. (1982) (3)
Decreased male fertility induced by chronic alcohol ingestion. Abstr. (1980) (3)
Chemistry, contraceptive activity and toxicology of aryl guanidinobenzoates: inhibitors of sperm acrosin (1985) (3)
Spermicidal effect of gossypol in an in vivo animal model for vaginal contraceptives (1981) (3)
Does sperm motility reflect the potential penetrating capacity? (1986) (2)
Development of a steerable hysteroscope: studies in the baboon. (1975) (2)
Aryl 4-Guanidinobenzoates: Potential Vaginal Contraceptives (1988) (2)
No change in acrosome reaction of human spermatozoa during storage in cervical mucus * (2009) (2)
4-Acetamidophenyl esters and 4-acetamidoanilides of L-arginine,p-guanidino-L-phenylalanine, L-lysine, N2-[D-fructos-3-O-yl and D-glucos-3-O-yl]acetyl-L-lysine as potential acrosin inhibitors (1991) (2)
Development of a new reversible vas deferens occlusion device. (1986) (2)
Preincubation of human spermatozoa in test-yolk medium: Effect on penetration of zona-free hamster oocytes and correlation with other semen characteristics (1989) (2)
Development of a reversible vas deferens occlusion device. VII. Physical and microscopic observations after long-term implantation of flexible prosthetic devices. (1980) (2)
New studies with intravasal devices. The soft valve. (1976) (2)
Synthesis of Diastereomeric Ketoconazole Analogs. (1991) (1)
Additional properties of acrosin, a proteolytic enzyme from rabbit sperm acrosomes (1972) (1)
Intrauterine contraception and its side-effects: effects of local proteinase inhibition. (1978) (1)
Effect of in vitro capacitation and acrosome reaction on acrosin system of guinea pig spermatozoa. (1980) (1)
Wheat germ agglutinin treatment of follicle cell-free mouse oocytes inhibits fertilization. (1988) (1)
Reversible vas deferens occlusion: a new device. (1978) (0)
A reversible vas deferens occlusive device: development and evaluation [abstract] (1986) (0)
An attempt to fertilize human oocytes with epidiymal spermatozoa in vitro (1984) (0)
INHIBITION OF HUMAN ACROSIN BY MONOSACCHARIDES AND RELATED COMPOUNDS: STRUCTURE-ACTIVITY RELATIONSHIPS (1982) (0)
[Behavior of chymotrypsin-like proteinase from human spermatozoa towards protein-proteinase inhibitors]. (1972) (0)
The lack of mutagenicity of aryl 4-guanidinobenzoates in the transplacental micronucleus assay in mice. (1990) (0)
Development of a Reversible Vas Deferens Occlusive Device: V. Flexible Prosthetic Devices**Supported by the Contraceptive Development Branch, Center for Population Research, National Institute of Child Health and Human Development, NIH, contract NIH-NICHD-71-2229. (1975) (0)
4‐Acetamidophenyl Esters and 4‐Acetamidoanilides of L‐Arginine, p‐ Guanidino‐L‐phenylalanine, L‐Lysine, N2‐(D‐Fructos‐3‐O‐yl and D‐Glucos‐ 3‐O‐yl)acetyl‐L‐lysine as Potential Acrosin Inhibitors. (1992) (0)
Analysis of electroejaculated mouse semen: a rapid assessment of male fertility. Abstr. (1980) (0)
An artificial vas deferens. (1974) (0)
Penetrating ability and ultrastructural categorization of human sperm cryopreserved in TESTCY (1982) (0)
Bacterial Vaginosis Anaerobes Commonly Associated with and Gardnerella vaginalis Sulfate) Inhibit (Polystyrene Sulfonate and Cellulose Two Novel Vaginal Microbicides (2014) (0)
A prosthetic vas deferens. (1976) (0)
Inhibition of HumanAcrosinby Fructose andOther Monosaccharides (1980) (0)
Compositions and their use to trap and inactivate pathogenic microbes and sperm count. (2001) (0)
Development of a Reversible Vas Deferens Occlusive Device: IV. Rigid Prosthetic Devices**Supported by the Contraceptive Development Branch, Center for Population Research, National Institute of Child Health and Human Development, National Institutes of Health contract no. NIHNICHD-71-2229. (1975) (0)
The use of cellulose sulfate and other sulfated polysaccharides in the prevention and treatment of papilloma virus infections (2001) (0)
Antifibrinolytic agents for control of IUD-induced bleeding. (1979) (0)
Discussion: studies of LHRH analogs in the human male. (1981) (0)
Human Immunodeficiency Virus (HIV) Cervicovaginal Shedding During the Menstrual Cycle in Seropositive Women Followed at a Specialized Care Center in São Paulo (2008) (0)
Purification ofPlasminogen Activators fromHumanSeminal Plasma (1978) (0)
Decrease of IUD-associated side effects through intrauterine application of proteinase inhibitors. (Abstract only) (1975) (0)
QUALITY ASSURANCE OF SPERM COUNTING. AUTHORS' REPLY (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lourens J. D. Zaneveld?

Lourens J. D. Zaneveld is affiliated with the following schools:

Rush University